Dr. Sulaiman Al Habib Medical Services Co. intrinsic value and dividend analysis using DCF, P/B, PEG and PSG models. Includes dividend yield, payout ratio, and dividend sustainability assessment. Sector: Health Care Equipment & Svc. Listed on Saudi Exchange Tadawul.
Dr. Sulaiman Al Habib Medical Services Group Company provides private healthcare through hospitals, medical complexes, and pharmacies in Saudi Arabia, organized across its Hospitals/Healthcare Facilities, Pharmacies, and Other Solutions Sector segments. It also offers home medical care, telemedicine, and facility maintenance services. The company was founded in 1993 and is based in Riyadh.
TASIV estimates this company's intrinsic value using a DCF (Discounted Cash Flow) model. As of TASIV's most recent data refresh, the estimated intrinsic value is SAR 184.15 compared to a market price of SAR 232.70 (Trading above DCF model value). This is an analytical estimate, not investment advice.
Revenue increased by about 44% over the three-year period, while net income grew at a considerably slower rate of approximately 17%, indicating that profitability did not keep pace with sales growth. Operating cash flow grew more slowly still, up by about 5% overall, after dipping in the second year and then recovering in the third. Overall, the company's historical financial performance shows revenue growth that outpaced comparatively modest growth in both net income and operating cash flow.
Dividend per share fluctuated over the 5-year recorded period, ranging between SAR 2.32 and SAR 4.75, and ended at SAR 2.32 versus SAR 3.25 at the start. Payments have been made on a Quarterly basis throughout this period. Overall, the company's per-share dividend has varied year to year without a consistent direction. Current dividend yield is approximately 2.04%, with a payout ratio of approximately 69.23%.
TASIV's Competitive Advantage assessment for this company is High (86/100), based on profitability, predictability, financial strength, and growth resilience.
Based on TASIV's DCF (Discounted Cash Flow) model, the estimated intrinsic value of Dr. Sulaiman Al Habib Medical Services Co. is approximately SAR 184.15, compared to a current market price of SAR 232.70. This is an analytical estimate based on the company's financial data, not investment advice or a recommendation to buy or sell.
According to TASIV's model, Dr. Sulaiman Al Habib Medical Services Co. is currently "Trading above DCF model value".
Dr. Sulaiman Al Habib Medical Services Co.'s dividend yield is approximately 2.04%, with a payout ratio of approximately 69.23%, based on TASIV's most recent verified data.
Loading 4013...